67,208 Fresh COVID-19 Cases in India; Death Toll Reaches 3.81 Lakh
Catch all the updates on the coronavirus outbreak here.
India on Thursday, 17 June, reported 67,208 new coronavirus cases, taking the tally in the country to 2,97,00,313. The death toll increased by 2,330 to 3,81,903.
Meanwhile, the Serum Institute of India (SII) plans to start clinical trials of the Novavax shot for children in July, sources were quoted as saying by news agency ANI on Thursday.
SII hopes to introduce Covavax, which is a version of US firm Novavax's COVID-19 vaccine candidate, in the country by September, the sources added.
Delhi on Thursday reported 158 new coronavirus cases, with a positivity rate of 0.20 percent, and 10 deaths
The soft launch of the Sputnik V vaccine in India, which was initiated in Hyderabad, has been scaled up to many cities, but the registration on CoWIN is not open to public yet, Dr Reddy’s said on Wednesday
(At The Quint, we are answerable only to our audience. Play an active role in shaping our journalism by becoming a member. Because the truth is worth it.)
India Reports Spike of 67,208 Fresh COVID Cases
India on Thursday, 17 June, reported 67,208 new coronavirus cases, taking the tally in the country to 2,97,00,313. The death toll increased by 2,330 to 3,81,903.
158 New COVID Cases in Delhi, Positivity Rate 0.20%
Delhi on Thursday reported 158 new coronavirus cases, with a positivity rate of 0.20 percent, and 10 deaths.
Serum Institute Likely to Start Novavax Trials for Children in July
The Serum Institute of India (SII) plans to start clinical trials of the Novavax shot for children in July, sources were quoted as saying by news agency ANI on Thursday.
SII hopes to introduce Covavax, which is a version of US firm Novavax's COVID-19 vaccine candidate, in the country by September, the sources added.
9,830 New COVID Cases in Maharashtra
Maharashtra on Thursday reported 9,830 new coronavirus cases and 236 fatalities.